NCT07740720 clinical trial report covering Dostarlimab-gxly, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07745504 clinical trial report covering Cagrilintide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743606 clinical trial report covering Naproxen, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743983 clinical trial report covering BGM-0504, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743580 clinical trial report covering Secutrelvir, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743593 clinical trial report covering Fluconazole, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07746089 clinical trial report covering ARGX-119, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743671 clinical trial report covering Engasertib, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07743489 clinical trial report covering Rose Bengal disodium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07745296 clinical trial report covering Futibatinib, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

Abgenix, Inc BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.

1910 Genetics BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.